Showing results (21-30 of 57) with videos related to
Sort By:
Pageof 6
Oncotarget|May 29, 2018
Efficacy and safety of carfilzomib in relapsed and/or refractory multiple myeloma: systematic review and meta-analysis of 14 trialsChintan Shah, Rohit Bishnoi, Yu Wang, et al.The Journal of Pharmacology and Experimental Therapeutics|October 8, 2004
Retinoic acid down-regulates aldehyde dehydrogenase and increases cytotoxicity of 4-hydroperoxycyclophosphamide and acetaldehydeJan S Moreb, Amir Gabr, Govind R Vartikar, et al.Journal of Virology|February 8, 2013
Myxoma and vaccinia viruses bind differentially to human leukocytesWinnie M Chan, Eric C Bartee, Jan S Moreb, et al.Leukemia & Lymphoma|February 22, 2018
Cardiotoxicity associated with carfilzomib: systematic review and meta-analysisChintan Shah, Rohit Bishnoi, Ankur Jain, et al.Immunology|September 11, 2009
Diverse T-cell differentiation potentials of human fetal thymus, fetal liver, cord blood and adult bone marrow CD34 cells on lentiviral Delta-like-1-modified mouse stromal cellsEkta Patel, Bei Wang, Lily Lien, et al.Chemico-Biological Interactions|November 15, 2011
The enzymatic activity of human aldehyde dehydrogenases 1A2 and 2 (ALDH1A2 and ALDH2) is detected by Aldefluor, inhibited by diethylaminobenzaldehyde and has significant effects on cell proliferation and drug resistanceJan S Moreb, Deniz Ucar, Shuhong Han, et al.Molecular Cancer|November 26, 2008
ALDH isozymes downregulation affects cell growth, cell motility and gene expression in lung cancer cellsJan S Moreb, Henry V Baker, Lung-Ji Chang, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|December 12, 2007
Overcoming immune tolerance against multiple myeloma with lentiviral calnexin-engineered dendritic cellsShuhong Han, Bei Wang, Matthew J Cotter, et al.Journal of Immune Based Therapies and Vaccines|November 26, 2010
Ex vivo development, expansion and in vivo analysis of a novel lineage of dendritic cells from hematopoietic stem cellsShuhong Han, Yichen Wang, Bei Wang, et al.Cardiovascular Toxicology|October 13, 2017
Unanticipated Cardiotoxicity Associated with Targeted Anticancer Therapy in Patients with Hematologic Malignancies Patients: Natural History and Risk FactorsChintan Shah, Yan Gong, Anita Szady, et al.Pageof 6